Colgate-Palmolive (NYSE:CL) Holdings Decreased by Baldwin Wealth Partners LLC MA

Baldwin Wealth Partners LLC MA lessened its stake in Colgate-Palmolive (NYSE:CL) by 9.4% during the 4th quarter, Holdings Channel reports. The institutional investor owned 2,317 shares of the company’s stock after selling 240 shares during the quarter. Baldwin Wealth Partners LLC MA’s holdings in Colgate-Palmolive were worth $211,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Parsons Capital Management Inc. RI lifted its stake in Colgate-Palmolive by 1.0% in the fourth quarter. Parsons Capital Management Inc. RI now owns 15,521 shares of the company’s stock valued at $1,411,000 after acquiring an additional 154 shares during the last quarter. Mount Yale Investment Advisors LLC increased its position in Colgate-Palmolive by 5.5% in the 4th quarter. Mount Yale Investment Advisors LLC now owns 3,299 shares of the company’s stock worth $300,000 after buying an additional 173 shares during the period. United Asset Strategies Inc. raised its stake in Colgate-Palmolive by 7.7% during the 4th quarter. United Asset Strategies Inc. now owns 111,438 shares of the company’s stock valued at $10,131,000 after purchasing an additional 7,924 shares during the last quarter. Cornerstone Wealth Group LLC raised its position in shares of Colgate-Palmolive by 4.0% during the fourth quarter. Cornerstone Wealth Group LLC now owns 41,970 shares of the company’s stock valued at $3,816,000 after buying an additional 1,599 shares during the last quarter. Finally, Union Bancaire Privee UBP SA bought a new stake in shares of Colgate-Palmolive in the 4th quarter worth approximately $32,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on CL. Piper Sandler decreased their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. JPMorgan Chase & Co. lowered their target price on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a research note on Thursday, January 16th. Barclays dropped their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research report on Friday, January 17th. Wells Fargo & Company cut their target price on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. Finally, UBS Group reduced their price target on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a research report on Thursday, January 16th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $101.11.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $91.19 on Tuesday. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The company’s fifty day simple moving average is $91.81 and its 200-day simple moving average is $97.45. The firm has a market cap of $74.50 billion, a PE ratio of 26.13, a P/E/G ratio of 3.59 and a beta of 0.44. Colgate-Palmolive has a 12 month low of $82.68 and a 12 month high of $109.30.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.19%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 57.31%.

Insider Activity

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.34% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.